Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 425 of 1,261
  1. US 10646517

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  2. US 10646484

    Methods to treat opioid use disorder

    Indivior UK Limited · Granted May 12, 2020 · Expires May 7, 2040

    granted
  3. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  4. US 10646474

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  5. US 10646480

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  6. US 10646443

    Sustained release olanzapine formulations

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted May 12, 2020 · Expires May 7, 2040

    granted
  7. US 10646435

    Pasty bio-adhesive sustained release compositions

    CARE & PHARMA PERSPECTIVES SA · Granted May 12, 2020 · Expires May 7, 2040

    granted
  8. US 10647710

    Thiazole derivative and applications thereof

    Medshine Discovery Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  9. US 10647697

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  10. CA 3118090

    COMPOSITIONS ET PROCEDES POUR EDITION DU GENOME A MEDIATION PAR NHEJ

    CRISPR THERAPEUTICS AG [CH] · Granted May 7, 2020 · Expires May 2, 2040

    granted
  11. AR 113437

    INHIBIDORES MITOCONDRIALES PARA EL TRATAMIENTO DE TRASTORNOS DE PROLIFERACIÓN

    BASILEA PHARM INT AG [CH] · Granted May 6, 2020 · Expires May 1, 2040

    granted
  12. US 10639303

    Alkaloids and their preparation and application as anti-HSV-1 agents

    OCEAN UNIVERSITY OF CHINA · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  13. US 10640493

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  14. US 10639330

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  15. US 10639350

    Methods and pharmaceutical compositions for improving wound healing using CD24

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  16. US 10640570

    Chimeric antigen receptors, compositions, and methods

    Regents of the University of Minnesota · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  17. US 10640791

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  18. US 10640501

    Methods of preparing inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  19. US 10640517

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  20. US 10639277

    Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma

    The Board of Regents of the University of Texas System · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  21. US 10639278

    Delivery of agents using metastable liposomes

    LIPELLA PHARMACEUTICALS, INC. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  22. US 10640571

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  23. US 10640771

    Compositions and methods for treating and preventing macular degeneration

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  24. US 10640770

    Hepatitis D virus (HDV) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.